Drug
Cv9201
Cv9201: highest development phase Phase 1/2, developed by CureVac. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CV9201 NCT00923312 | Phase 1/2 | Non Small Cell Lung Cancer |
Latest
No recent events.
Follow Cv9201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.